Contrast-induced nephropathy: update with special emphasis on patients with diabetes.
Contrast-induced nephropathy (CIN) continues to be a significant complication of the increasing use of iodinated contrast media. There have been few new insights into pathogenesis; despite multiple strategies aimed at prophylaxis, very few have proven efficacious. This article reviews our current knowledge regarding CIN, with emphasis on patients with diabetes.
Solomon
Richard
R
Fletcher Allen Health Care, University of Vermont School of Medicine, UHC 2309, 1 South Prospect Street, Burlington, VT 05401, USA. richard.solomon@vtmednet.org
D003287:Contrast Media / Q000009:adverse effects*; D003928:Diabetic Nephropathies / Q000139:chemically induced* / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D006435:Renal Dialysis
D003287:Contrast Media